The FDA clearance of the drug followed by further applications for it....there's no reason for the stock to be down this low except lack of news. If this stock had any news that went viral and goes up violently on volume, I think we could easily see back in the $1.50 - $2.00 range. The market cap with the potential...something just is not sizing up here. Hang in there longs...
I was also under an optimistic impression until I read the transcript of the last CC:
"Now our capitalization at the end of January, which includes this $6 million in preferred shares purchased in January 2013, totaled approximately 206 million shares on an as-converted and fully diluted basis."
"What would be the number of outstanding shares in a change of control scenario?"
"There are a lot, there are a variety of different scenarios but it could go as high as 450 million shares."
"As of December 31, 2012, we had current assets of $3.5 million including cash and cash equivalents of $3 million....... Please note that in January 2013, we brought in additional gross proceeds of $6 million from the sale of Series A-3 preferred stock."
"........we anticipate potential cash usage during 2013 of approximately $20 million to $25 million."
I get what you are saying, but Market cap doesn't include stock associated with debt obligations. Including these, true market cap can balloon to $400M. Look around. Listen to conference calls. This is impacting the ability to strike a licensing deal.
I listened to the last annual conference call so I know they have a max of 450 million shares and they finance a lot using preferred shares. Does it seem odd to you that end of May they run out of money and no news yet? I guess we know there will be either further dilution or a deal coming down the pipes...The other question is does a company usually hire a company to work on a strategic deal with or without a potential deal in the workings? Just trying to gauge the odds on what could be happening...There's got to be a large company out there that would love to have this Leukemia cancer treatment technology...